Genetic diversity of SARS-CoV-2 in Croatia (CROSBI ID 705665)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Ferenčak, Ivana ; Kuzle, Josipa ; Mišić, Anita ; Bocka, Bojana ; Stevanović, Vladimir ; Hruškar, Željka ; Smoljo, Petra ; Lovrić, Zvjezdana ; Jukić, Ana ; Barbić, Ljubo ; Vilibić-Čavlek, Tatjana ; Tabain, Irena
engleski
Genetic diversity of SARS-CoV-2 in Croatia
SARS-CoV-2 as an RNA virus with a large genome is subject to rapid mutation as it replicates. Among silent or deleterious mutations are the one that creates variants with a selective advantage. In late 2020 and early 2021 emerged variants that appear to be more transmissible than existing strains, evade immunologic response and induce more severe disease. Three variants that rapidly became dominant in specific area and were designated variant of concern (VOC) are: VOC- 202012/01 (B.1.1.7), 501Y.V2 (B.1.351) and P.1 (B.1.1.28.1). To this date GISAID acknowledges two more VOCs: GH/452R.V1 (B.1.429+B.1.427) and G/484K.V3 (B.1.525). To monitor the epidemiologic situation we followed ECDC recommendation and conduct whole-genome sequencing (WGS) on 5-10% SARS-CoV-2 positive samples in Croatia. WGS is performed weekly from 09.02.2021. Obtained sequences are uploaded to GISAID database and isolates are categorized in phylogenetic clades depending on single nucleotide polymorphism (SNP) present in the genome. By the end of March 2021 we processed 2632 samples. 1901 samples were successfully sequenced. Between the second and third waves of the epidemic, virus lineages from clade G, GR and GV were dominant, but marked weekly increase of GRY clade indicated the beginning of the third epidemic wave in Croatia. Delivered results showed marked continuous increase in B.1.1.7 presence from 21.23% in the first week of testing, to 94.27% in the last week of March. Variant B.1.351 from GH clade was detected in 15 samples, mainly related to travelling abroad and their close contacts. B.1.526 detected in 4 samples carry mutation essential for the loss of neutralizing activity of some monoclonal antibodies and is considered variant of interest.
SARS-CoV-2 ; variants ; epidemiology ; Croatia
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
129-129.
2021.
objavljeno
Podaci o matičnoj publikaciji
Zbornik kratkih sadržaja
Petrović, Tamaš
Beograd: Srpsko veterinarsko društvo
978-86-83115-41-9
Podaci o skupu
XXII/XXIII Simpozijum epizootiologa i epidemiologa
predavanje
26.04.2021-28.04.2021
Beograd, Srbija